Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1256
Book Description
Preclinical and Clinical Testing by the Pharmaceutical Industry, 1976
Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1256
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1256
Book Description
Preclinical and Clinical Testing by the Pharmaceutical Industry, 1975[-1976]
Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 492
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 492
Book Description
Preclinical and Clinical Testing by Pharmaceutical Industry, 1975
Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 820
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 820
Book Description
Preclinical and clinical testing by the pharmaceutical industry, 1977
Author: United States. Congress. Senate. Committee on Human Resources. Subcommittee on Health and Scientific Research
Publisher:
ISBN:
Category :
Languages : en
Pages : 622
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 622
Book Description
Preclinical and Clinical Testing by the Pharmaceutical Industry, 1975
Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 264
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 264
Book Description
Preclinical and Clinical Testing by the Pharmaceutical Industry, 1975-
Author: United States. Congress. Senate. Committee on Labor and Public Welfare
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 344
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 344
Book Description
Preclinical and Clinical Testing by Pharmaceutical Industry, 1976
Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 496
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 496
Book Description
Modern Methods of Clinical Investigation
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309042860
Category : Medical
Languages : en
Pages : 241
Book Description
The very rapid pace of advances in biomedical research promises us a wide range of new drugs, medical devices, and clinical procedures. The extent to which these discoveries will benefit the public, however, depends in large part on the methods we choose for developing and testing them. Modern Methods of Clinical Investigation focuses on strategies for clinical evaluation and their role in uncovering the actual benefits and risks of medical innovation. Essays explore differences in our current systems for evaluating drugs, medical devices, and clinical procedures; health insurance databases as a tool for assessing treatment outcomes; the role of the medical profession, the Food and Drug Administration, and industry in stimulating the use of evaluative methods; and more. This book will be of special interest to policymakers, regulators, executives in the medical industry, clinical researchers, and physicians.
Publisher: National Academies Press
ISBN: 0309042860
Category : Medical
Languages : en
Pages : 241
Book Description
The very rapid pace of advances in biomedical research promises us a wide range of new drugs, medical devices, and clinical procedures. The extent to which these discoveries will benefit the public, however, depends in large part on the methods we choose for developing and testing them. Modern Methods of Clinical Investigation focuses on strategies for clinical evaluation and their role in uncovering the actual benefits and risks of medical innovation. Essays explore differences in our current systems for evaluating drugs, medical devices, and clinical procedures; health insurance databases as a tool for assessing treatment outcomes; the role of the medical profession, the Food and Drug Administration, and industry in stimulating the use of evaluative methods; and more. This book will be of special interest to policymakers, regulators, executives in the medical industry, clinical researchers, and physicians.
Preclinical and Clinical Testing by the Pharmaceutical Industry, 1975
Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1662
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1662
Book Description
The Changing Economics of Medical Technology
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 030904491X
Category : Medical
Languages : en
Pages : 225
Book Description
Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.
Publisher: National Academies Press
ISBN: 030904491X
Category : Medical
Languages : en
Pages : 225
Book Description
Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.